MO1-12-1Clinical introduction of Microsatellite instability (MSI) test for the Solid Tumors at a single institute

Abstract Backgrounds Pembrolizumab is recently approved in Japan for the microsatellite instability-high (MSI-H) solid tumor patients (pts) diagnosed with Promega panel (FALCOTM). Pembrolizumab is the first anti-tumor agent based on the biomarker, regardless of tumor types. MSI test has been perform...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2019-10, Vol.30 (Supplement_6)
Hauptverfasser:	Nakayama, Izuma, Shinozaki, Eiji, Kawachi, Hiroshi, Nakajima, Takeshi, Sasaki, Takashi, Kanata, Ryo, Yunokawa, Mayu, Matoda, Maki, Tomomatsu, Jyunishi, Kitazono, Satoshi, Yuasa, Takeshi, Kobayashi, Kokoro, Toko, Chieko, Kaihara, Kazumi, Nakano, Yasuhiro, Kakita, Tomoyo, Takahashii, Shunnji, Yamaguchi, Kensei
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!